BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 15, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Sankyo claims allosteric muscarinic effectors for AD
May 17, 1996
GP-3269 on track for clinical testing
May 17, 1996
SB-204269 in phase I for epilepsy
May 17, 1996
Ketoconazole: Potential treatment for depression?
May 17, 1996
Scios to copromote venlafaxine with Wyeth-Ayerst
May 17, 1996
5-HT1D antagonists disclosed by SmithKline Beecham
May 17, 1996
Pfizer claims 5-HT1 agonists and antagonists for CNS disorders
May 17, 1996
Sertindole clinical trial results reported at APA meeting
May 17, 1996
NIH scientists report ligands for alpha5-containing GABA-A receptors
May 17, 1996
Paroxetine approved for new indication
May 17, 1996
Previous
1
2
…
2733
2734
2735
2736
2737
2738
2739
2740
2741
…
2748
2749
Next
RSS